Journals / Southern Clinics of Istanbul Eurasia / 2018 / Cilt: 29 - Sayı: 1

Comparison of PET/CT with Invasive Staging and Pathological Staging of Lung Cancer; Analysis of 240 Cases

Pages
1–7
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Total mediastinal lymph node dissection can determine the accurate stage of the disease and aid in determining the prognosis and treatment protocol.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: After a lung cancer diagnosis, determination of tumor invasion and involvement of mediastinal lymph nodes will indicate tumor stage and operability.
📊
Key Findings & Data:The aim of this study was to compare and analyze the lymph node metastasis findings of positron emission to-mography–computed tomography (PET/CT) using invasive staging methods and pathological staging in 240 lung cancer cases.Methods: The PET/CT examination of 240 patients included in the study revealed true positivity in 60 patients, false positivity in 45, true negativity in 103, and false negativity in 4 patients.
💡
Conclusion & Impact:Total mediastinal lymph node dissection can determine the accurate stage of the disease and aid in determining the prognosis and treatment protocol.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: After a lung cancer diagnosis, determination of tumor invasion and involvement of mediastinal lymph nodes will indicate tumor stage and operability. The aim of this study was to compare and analyze the lymph node metastasis findings of positron emission to-mography–computed tomography (PET/CT) using invasive staging methods and pathological staging in 240 lung cancer cases.Methods: The PET/CT examination of 240 patients included in the study revealed true positivity in 60 patients, false positivity in 45, true negativity in 103, and false negativity in 4 patients. Univariate analysis indicated that the incidence of occult N2 disease was found to be statistically significantly higher in right upper lobe tumors (p=0.01).Results: Of the 240 patients evaluated, mediastinal sampling was performed using endo-bronchial ultrasound (EBUS) in 160 patients, and mediastinoscopy in 80 patients.The high specificity rate of mediastinoscopy was found to be close to the accuracy of EBUS.Conclusion: As a result of the high specificity and accuracy rates, EBUS and mediastinoscopy are among the predominant staging methods. However,we think that mediastinoscopy is still the gold standard method. Total mediastinal lymph node dissection can determine the accurate stage of the disease and aid in determining the prognosis and treatment protocol.

🔖

Cite This Article

ÖZER, K. B., CESUR, E. E., ÖZDEMİR, A., ÖZLÜ, F. T., DEMİRHAN, R., CÖMERT, S. Ş. (2018). Comparison of PET/CT with Invasive Staging and Pathological Staging of Lung Cancer; Analysis of 240 Cases. Southern Clinics of Istanbul Eurasia, Cilt: 29 - Sayı: 1, 1–7. https://ajindex.com/articles/314175

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23–47
  2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108 3. Ece T. Akciğer kanserine genel bakış. In: Aydıner A, Can G, editors. Akciğer Kanserinde. Tedavi ve Bakım. Istanbul: İpomet Matbaacılık; 2010. p. 1–6
  3. Akciğer ve Plevra Maligniteleri Çalışma Grubu. Akciğer kanseri tanı ve tedavi rehberi. Toraks Dergisi 2006;7:1–37
  4. Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V. Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. Lung Cancer 2008;60:62–8
  5. Semik M, Schmid C, Trösch F, Broermann P, Scheld HH. Lung can-cer surgery—preoperative risk assessment and patient selection. Lung Cancer 2001;S9–15
  6. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F; American College of Chest Physicians. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003;123:147–56S
  7. Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, et al. The additional value of FDG PET imaging for dis-tinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med 2007;32:607–12
  8. Tolaza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003;123:137–46S
  9. Scott WJ, Dewan NA. Use of positron emission tomography to diag-nose and stage iung cancer. Clin Pulm Med 1999;6:198–204
  10. Kernstine KH, McLaughlin KA, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, et al. Can FDG-PET Reduce the Need for Medi-astinoscopy in Potentially Resectable Nonsmall Cell Lung Cancer? Ann Thorac Surg 2002;73:394–402
  11. Stroobants SG, D’Hoore I, Dooms C, De Leyn PR, Dupont PJ, De Wever W, et al. Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer. Clin Lung Cancer 2003;4:242–7
  12. Güneren G. Küçük Hücreli Dışı Akciğer Kanserlerinde Klinik Evrelemede Kullanılan PET-CT’nin patolojik evreleme ile karşılaştırılması [Uzmanlık Tezi]. İstanbul: Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Cerrahisi Kliniği; 2006
  13. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et